Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06844110
NA

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

68Ga-DOTA-dPNE PET/CT imaging was performed on patients with malignant tumors to observe the binding of lesions with the tracer and evaluate the expression of CD73. At the same time, correlation analysis was performed combined with relevant clinical indicators to evaluate the efficacy of 68Ga-DOTA-dPNE in the diagnosis and guidance of malignant tumor patients, and predict the response of targeted therapy.

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-03-01

Completion Date

2026-03-30

Last Updated

2025-08-05

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

68GA-DOTA-dPNE

Intravenous administration of 68GA-DOTA-dPNE tracer

Locations (1)

PUMCH

Dongcheng, Beijing Municipality, China